Home/Investors/PMV

PMV

Biotech Investor · 3 portfolio companies

Portfolio

3

Focus Areas

5

Top Stage

phase-2

Investment Focus

Infectious Disease Oncology Alzheimer's Disease Huntington's Disease Amyotrophic Lateral Sclerosis (ALS)

Portfolio Companies

Company	Stage	Valuation	Focus
eTheRNA	phase-2	—	Infectious Disease, Oncology
reMYND	Pre-clinical	—	Alzheimer's Disease, Huntington's Disease
Trince	—	—	—

Frequent Co-Investors

Novalis Biotech Acceleration1 shared Bristol Myers Squibb (via partnership)1 shared Private Investors1 shared Korys1 shared SFPIM1 shared European Innovation Council (EIC) Fund1 shared Maatschap Winstock1 shared Qbic1 shared